Fosaprepitant (supportive therapy in cancer treatment)

Fosaprepitant (supportive therapy in cancer treatment) is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about fosaprepitant (supportive therapy in cancer treatment) automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain fosaprepitant (supportive therapy in cancer treatment), including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - fosaprepitant (supportive therapy in cancer treatment)

Audience:
       

(Medicine)
06 Nov 2014 Emend IV 150 mg Powder for infusion (supportive therapy in cancer treatment) is a brand of medicine containing the active ingredient fosaprepitant dimeglumine (supportive therapy in cancer treatment). Find out about side effects, who can take it and who shouldn’t use Emend IV 150 mg Powder for infusion (supportive therapy in cancer treatment) by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.

Medicine brands that contain fosaprepitant (supportive therapy in cancer treatment)